Clinical Trial Update: A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC. [NA]

View source ↗

Summary

A clinical study evaluating the efficacy and safety of combining oral all-trans retinoic acid with toripalimab in triple-negative breast cancer, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• Toripalimab (Toripalimab)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Triple-negative Breast Cancer | NA | Status: RECRUITING